Biomarkers of vascular complications in type 2 diabetes

Metabolism: Clinical and Experimental

Volumn 64, Issue 3, 2015, Pages S28-S32

  Tremblay, Johanne ^a   Hamet, Pavel ^a  

^a CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

Early biomarkers; genomics; personalized medicine; primary prevention

Indexed keywords

ADIPONECTIN; AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; BIOLOGICAL MARKER; C REACTIVE PROTEIN; FIBRINOGEN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INTERLEUKIN 6; LOW DENSITY LIPOPROTEIN; MICRORNA 122; MICRORNA 126; OSTEOGENIC PROTEIN 1; TRANSFORMING GROWTH FACTOR BETA1; TROPONIN;

ACUTE CORONARY SYNDROME; ALBUMINURIA; ARTICLE; BRAIN ISCHEMIA; CARDIOVASCULAR RISK; CAUCASIAN; CHOLESTEROL BLOOD LEVEL; CHROMOSOME 10Q; CHROMOSOME 1P; CHROMOSOME 1Q; CHROMOSOME 2Q; CLINICAL TRIAL (TOPIC); CORONARY ARTERY DISEASE; DIABETIC ANGIOPATHY; DIABETIC CARDIOMYOPATHY; DIABETIC NEPHROPATHY; FIBRINOGEN BLOOD LEVEL; GENE LOCUS; GENETIC ASSOCIATION; HERITABILITY; HOSPITAL PATIENT; HUMAN; META ANALYSIS (TOPIC); MICROALBUMINURIA; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; SENSITIVITY AND SPECIFICITY; SINGLE NUCLEOTIDE POLYMORPHISM; BLOOD; COMPLICATION; DIABETIC ANGIOPATHIES; DIABETIC NEPHROPATHIES; PERSONALIZED MEDICINE; PREDICTIVE VALUE; PRIMARY PREVENTION; RISK ASSESSMENT;

BIOLOGICAL MARKERS; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; DIABETIC NEPHROPATHIES; HUMANS; INDIVIDUALIZED MEDICINE; PREDICTIVE VALUE OF TESTS; PRIMARY PREVENTION; RISK ASSESSMENT;

EID: 84920877078     PISSN: 00260495     EISSN: 15328600     Source Type: Journal    
DOI: 10.1016/j.metabol.2014.10.032     Document Type: Article

References (30)

1. IDF Diabetes Atlas International Diabetes Federation 6th ed. 2013 International Diabetes Federation Brussels, Belgium [ http://www idf org/diabetesatlas]
2. A. Patel, S. MacMahon, and J. Chalmers Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial Lancet 370 2007 829 840
3. A. Patel, S. MacMahon, and J. Chalmers Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes N Engl J Med 358 2008 2560 2572
4. E.S. Huang, A. Basu, and M. O'Grady Projecting the future diabetes population size and related costs for the U.S. Diabetes Care 32 2009 2225 2229
5. G. Imperatore, J.P. Boyle, and T.J. Thompson Projections of type 1 and type 2 diabetes burden in the U.S. population aged < 20 years through 2050: dynamic modeling of incidence, mortality, and population growth Diabetes Care 35 2012 2515 2520
6. Rapid rise in hypertension and nephropathy in youth with type 2 diabetes: the TODAY clinical trial Diabetes Care 36 2013 1735 1741
7. M.I. Constantino, L. Molyneaux, and F. Limacher-Gisler Long-term complications and mortality in young-onset diabetes: type 2 diabetes is more hazardous and lethal than type 1 diabetes Diabetes Care 36 2013 3863 3869
8. J.L. Anderson, C.D. Adams, and E.M. Antman ACC/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-Elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction) developed in collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine J Am Coll Cardiol 50 2007 e1 e157
9. A.I. Adler UKPDS-modelling of cardiovascular risk assessment and lifetime simulation of outcomes Diabet Med 25 Suppl 2 2008 41 46
10. A.P. Kengne, A. Patel, and S. Colagiuri The Framingham and UK Prospective Diabetes Study (UKPDS) risk equations do not reliably estimate the probability of cardiovascular events in a large ethnically diverse sample of patients with diabetes: the Action in Diabetes and Vascular Disease: Preterax and Diamicron-MR Controlled Evaluation (ADVANCE) Study Diabetologia 53 2010 821 831
11. A.P. Kengne, A. Patel, and M. Marre Contemporary model for cardiovascular risk prediction in people with type 2 diabetes Eur J Cardiovasc Prev Rehabil 18 2011 393 398
12. S. Kaptoge, E. Di Angelantonio, and G. Lowe C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis Lancet 375 2010 132 140
13. J. Danesh, S. Lewington, and S.G. Thompson Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis JAMA 294 2005 1799 1809
14. G. Lowe, M. Woodward, and G. Hillis Circulating inflammatory markers and the risk of vascular complications and mortality in people with type 2 diabetes and cardiovascular disease or risk factors: the ADVANCE study Diabetes 63 2014 1115 1123
15. N.J. Samani, P. Deloukas, and J. Erdmann Large scale association analysis of novel genetic loci for coronary artery disease Arterioscler Thromb Vasc Biol 29 2009 774 780
16. M. Arregui, E. Fisher, and S. Knuppel Significant associations of the rs2943634 (2q36.3) genetic polymorphism with adiponectin, high density lipoprotein cholesterol and ischemic stroke Gene 494 2012 190 195
17. Intermountain Medical Center Genetic markers may predict when people with heart disease are likely to have heart attacks ScienceDaily, Ref Type: Magazine Article 2014 [ www.sciencedaily.com/releases/2014-03/140330193658 ]
18. L.C. Plantinga, D.C. Crews, and J. Coresh Prevalence of chronic kidney disease in US adults with undiagnosed diabetes or prediabetes Clin J Am Soc Nephrol 5 2010 673 682
19. R.G. Fassett, S.K. Venuthurupalli, and G.C. Gobe Biomarkers in chronic kidney disease: a review Kidney Int 80 2011 806 821
20. S. Zoungas, B.E. de Galan, and T. Ninomiya Combined effects of routine blood pressure lowering and intensive glucose control on macrovascular and microvascular outcomes in patients with type 2 diabetes: New results from the ADVANCE trial Diabetes Care 32 2009 2068 2074
21. M.G. Wong, V. Perkovic, and M. Woodward Circulating bone morphogenetic protein-7 and transforming growth factor-beta1 are better predictors of renal end points in patients with type 2 diabetes mellitus Kidney Int 83 2013 278 284
22. C.M. Forsblom, T. Kanninen, and M. Lehtovirta Heritability of albumin excretion rate in families of patients with Type II diabetes Diabetologia 42 1999 1359 1366
23. N. Sandholm, A.J. McKnight, and R.M. Salem Chromosome 2q31.1 associates with ESRD in women with type 1 diabetes J Am Soc Nephrol 24 2013 1537 1543
24. F. Thameem, R.P. Igo Jr., and B.I. Freedman A genome-wide search for linkage of estimated glomerular filtration rate (eGFR) in the Family Investigation of Nephropathy and Diabetes (FIND) PLoS One 8 2013 e81888
25. M.G. Pezzolesi, and A.S. Krolewski The genetic risk of kidney disease in type 2 diabetes Med Clin North Am 97 1 2013 91 107
26. A. Kottgen, C. Pattaro, and C.A. Boger New loci associated with kidney function and chronic kidney disease Nat Genet 42 2010 376 384
27. C.A. Boger, M.H. Chen, and A. Tin CUBN is a gene locus for albuminuria J Am Soc Nephrol 22 2011 555 570
28. C.B. Do, D.A. Hinds, U. Francke, and N. Eriksson Comparison of family history and SNPs for predicting risk of complex disease PLoS Genet 8 2012 e1002973
29. P. Hamet Missing heritability or need for reality check of clinical utility in genomic testing? J Hypertens 32 2014 1395 1396
30. M. Gorski, A. Tin, M. Garnaas, G.M. McMahon, A.Y. Chu, and B.O. Tayo Genome-wide association study of kidney function decline in individuals of European descent. Kidney Int 2014 Dec 10 [Epub ahead of print]